Status:

COMPLETED

Dry Cupping Therapy in Knee Osteoarthritis

Lead Sponsor:

Universidade Federal do Rio Grande do Norte

Conditions:

Osteo Arthritis Knee

Pain, Chronic

Eligibility:

FEMALE

50-75 years

Phase:

NA

Brief Summary

Introduction: Knee osteoarthritis (KOA) is the biggest cause of pain and disability worldwide. As a non-pharmacological approach, ventosatherapia has been used to control pain, improve function and qu...

Detailed Description

The intervention will be carried out for 15 minutes, twice a week, for 6 consecutive weeks, totaling 12 sessions. Both groups will be evaluated in 4 moments: before the intervention (T0), after 3 week...

Eligibility Criteria

Inclusion

  • Diagnosed with KOA based on ACR clinical criteria;
  • Knee pain intensity between 3 and 8, according to the Numerical Pain Scale (END);
  • BMI less than 35 kg / m2.

Exclusion

  • Having undergone physical therapy treatment for the knee in the 3 months prior to the project;
  • Be engaged in\> 45 minutes / week in accumulated physical activity of at least moderate intensity;
  • To have been submitted to the application and / or intervention with the wind therapy previously.
  • Have used corticosteroid infiltration in the knee in the last 6 months;
  • Present any medical restrictions that make it impossible for them to participate in the proposed assessments and interventions (cardiorespiratory, neurological and / or musculoskeletal changes);
  • Presenting a diagnosis of fibromyalgia, rheumatoid arthritis or some systemic inflammatory arthritis;
  • Presenting a ligament or meniscal injury diagnosed clinically or with a positive result in the Apley tests or anterior / posterior drawer;
  • Have had previous surgery on the ankle, knee or hip;
  • Present a clinical diagnosis of some dementia or inability to answer the questionnaires related to the study;
  • Present any contraindications for the use of ventosatherapia (skin lesion in the region where it will be applied, cancer, kidney failure, liver and heart failure, pacemaker, pregnancy);
  • Having uncontrolled diabetes and hypertension;
  • Have a trip scheduled for the two months following inclusion in the survey.

Key Trial Info

Start Date :

February 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 2 2023

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT04331158

Start Date

February 1 2023

End Date

December 2 2023

Last Update

June 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Marcelo Cardoso de Souza

Santa Cruz, Rio Grande do Norte, Brazil, 59200-000